Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Comment by jjwilsonon Apr 28, 2020 4:57pm
200 Views
Post# 30963712

RE:RE:FDA to better police, evaluate COVID-19 antibody tests

RE:RE:FDA to better police, evaluate COVID-19 antibody tests"140 antibody test companies in the US now."

It's getting harder and harder to predict which company to invest in to be part of this.

It would have been good to be a shareholder in Spartan, unfortunately it's privately held.

I'm invested in a couple of companies that have some part of the "treatment" of Covid-19, a couple that are trying to get a piece of the antigen testing market and a couple that are trying for a piece of the antibody testing market.

There's a significant amount of money to be made, along with some satisfaction from owning some small share of the company that comes out as the winner.  It's going to be very difficult to pick the winners though.  Back when I was investing mostly in junior miners I spent a lot of time learning geology and learning how to read reports on drill rod - thought that was difficult.  Now I'm spending all my time trying to learn how to differentiate between different kinds of antibody tests and the specifics of IgG and IgM antibodies.  Complicating this is the maze of commercial agreements between different companies, international standards and approval processes.

It's all very compicated I must say and on top of all of this you have the usual dirty tricks being played in the market and here on SH.



Bullboard Posts